Related Experiment Videos
Systolic and diastolic function in renal replacement therapy: a cross-sectional study
Giovambattista Virga1, Berardino Stomaci, Alessandra Munaro
1Nephrology and Dialysis Unit, P. Cosma Hospital, Camposampiero, Padova, Italy. virgolino14@libero.it
Journal of Nephrology
|June 1, 2006
Summary
Renal replacement therapy impacts heart function. Kidney transplant patients show better heart function compared to dialysis patients, despite higher rates of hypertension and left ventricular hypertrophy.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Heart disease is a leading cause of mortality in patients with kidney failure.
- Assessing cardiac function is crucial for patients undergoing renal replacement therapy (RRT).
Purpose of the Study:
- To evaluate and compare left ventricular (LV) systolic and diastolic function in patients on hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (TX).
Main Methods:
- A cohort of 125 RRT patients (61 HD, 30 PD, 34 TX) were assessed over six months.
- Systolic and diastolic function indices were compared across HD, PD, and TX groups.
- Analyses were adjusted for age, gender, and duration of RRT.
Main Results:
- Hemodialysis patients exhibited poorer systolic function (lower fractional shortening and ejection fraction) compared to transplant recipients.
- Peritoneal dialysis patients demonstrated worse diastolic function than transplant recipients, with over 80% showing pathological diastolic indices.
- Hypertension prevalence was high across all groups (TX: 88.2%, PD: 86.7%, HD: 50.8%), as was left ventricular hypertrophy (LVH) (TX: 55.9%, PD: 53.3%, HD: 36.1%).
Conclusions:
- Kidney transplant recipients maintained superior systolic and diastolic cardiac function compared to both hemodialysis and peritoneal dialysis patients.
- Despite better cardiac function, transplant recipients had higher rates of hypertension and LVH, suggesting complex cardiovascular risk profiles in RRT patients.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...